Metformin-Induced Reduction of CD39 and CD73 Blocks Myeloid-Derived Suppressor Cell Activity in Patients with Ovarian Cancer DOI Open Access
Lifeng Li, Liping Wang,

Jieyao Li

et al.

Cancer Research, Journal Year: 2018, Volume and Issue: 78(7), P. 1779 - 1791

Published: Jan. 26, 2018

Abstract Metformin is a broadly prescribed drug for type 2 diabetes that exerts antitumor activity, yet the mechanisms underlying this activity remain unclear. We show here metformin treatment blocks suppressive function of myeloid-derived suppressor cells (MDSC) in patients with ovarian cancer by downregulating expression and ectoenzymatic CD39 CD73 on monocytic polymononuclear MDSC subsets. triggered activation AMP-activated protein kinase α subsequently suppressed hypoxia-inducible factor α, which was critical induction CD39/CD73 MDSC. Furthermore, correlated longer overall survival diabetic cancer, accompanied metformin-induced reduction frequency circulating CD39+CD73+ concomitant increase activities CD8+ T cells. Our results highlight direct effect suggest may yield clinical benefit through improvement T-cell immunity dampening CD39/CD73-dependent immunosuppression patients. Significance: The an antidiabetes attributable to reduced immunosuppressive tumor Cancer Res; 78(7); 1779–91. ©2018 AACR.

Language: Английский

Oxygen battle in the gut: Hypoxia and hypoxia-inducible factors in metabolic and inflammatory responses in the intestine DOI Creative Commons
Rashi Singhal, Yatrik M. Shah

Journal of Biological Chemistry, Journal Year: 2020, Volume and Issue: 295(30), P. 10493 - 10505

Published: June 6, 2020

The gastrointestinal tract is a highly proliferative and regenerative tissue. intestine also harbors large diverse microbial population collectively called the gut microbiome (microbiota). microbiome-intestine cross-talk includes dynamic exchange of gaseous signaling mediators generated by bacterial intestinal metabolisms. Moreover, initiates maintains hypoxic environment that critical for nutrient absorption, barrier function, innate adaptive immune responses in mucosal cells intestine. response to hypoxia mediated hypoxia-inducible factors (HIFs). In conditions, HIF activation regulates expression cohort genes promote adaptation hypoxia. Physiologically, HIF-dependent contribute aforementioned maintenance epithelial regulation. However, chronic exacerbates disease leading injury, inflammation, colorectal cancer. this review, we aim outline major roles physiological pathological conditions homeostasis onset progression with focus on understanding complex pathophysiology

Language: Английский

Citations

260

FoxP3+ T regulatory cells in cancer: Prognostic biomarkers and therapeutic targets DOI Creative Commons
Reem Saleh, Eyad Elkord

Cancer Letters, Journal Year: 2020, Volume and Issue: 490, P. 174 - 185

Published: July 25, 2020

T Regulatory cells (Tregs) can have both protective and pathological roles. They maintain immune homeostasis inhibit responses in various diseases, including cancer. Proportions of Tregs the peripheral blood some cancer patients increase by approximately two-fold, compared to those healthy individuals. contribute development progression suppressing effector cell functions, thereby compromising tumor killing promoting growth. Highly immunosuppressive express upregulated levels transcription factor, Forkhead box protein P3 (FoxP3). Elevated FoxP3+ within microenvironment (TME) showed a positive correlation with poor prognosis patients. Despite success immunotherapy, use checkpoint inhibitors, significant proportion show low response rates as result primary or acquired resistance against therapy. Some mechanisms which underlie therapy are associated Treg suppressive function. In this review, we describe contribution development/progression, Treg-mediated immunosuppression. We discuss prognostic significance different cancers their potential biomarkers. also therapeutic strategies target combination other types immunotherapies aiming overcome improve clinical outcomes Overall, understanding could help more effective targeted enhance

Language: Английский

Citations

257

Targeting CD39 in cancer DOI
Achim K. Moesta, Xian-Yang Li, Mark J. Smyth

et al.

Nature reviews. Immunology, Journal Year: 2020, Volume and Issue: 20(12), P. 739 - 755

Published: July 29, 2020

Language: Английский

Citations

256

cGAS-STING pathway in cancer biotherapy DOI Creative Commons
Yang Wang, Jingwen Luo, Aqu Alu

et al.

Molecular Cancer, Journal Year: 2020, Volume and Issue: 19(1)

Published: Sept. 4, 2020

The activation of the cGAS-STING pathway has tremendous potential to improve anti-tumor immunity by generating type I interferons. In recent decades, we have witnessed that producing dsDNA upon various stimuli is an initiative factor, triggering cGAS-SING for a defensive host. understanding both intracellular cascade reaction and changes molecular components gains insight into IFNs adaptive immunity. Based on immunological study, STING-cGAS coupled cancer biotherapy. most challenging problem limited therapeutic effect. Therefore, people view 5, 6-dimethylxanthenone-4-acetic acid, cyclic dinucleotides derivative as agonists. Even so, these agonists flaws in decreasing biotherapeutic efficacy. Subsequently, exploited agonist delivery systems (nanocarriers, microparticles hydrogels). article will discuss underlying mechanisms, with introduction agonists, related clinical trials systems.

Language: Английский

Citations

250

Metformin-Induced Reduction of CD39 and CD73 Blocks Myeloid-Derived Suppressor Cell Activity in Patients with Ovarian Cancer DOI Open Access
Lifeng Li, Liping Wang,

Jieyao Li

et al.

Cancer Research, Journal Year: 2018, Volume and Issue: 78(7), P. 1779 - 1791

Published: Jan. 26, 2018

Abstract Metformin is a broadly prescribed drug for type 2 diabetes that exerts antitumor activity, yet the mechanisms underlying this activity remain unclear. We show here metformin treatment blocks suppressive function of myeloid-derived suppressor cells (MDSC) in patients with ovarian cancer by downregulating expression and ectoenzymatic CD39 CD73 on monocytic polymononuclear MDSC subsets. triggered activation AMP-activated protein kinase α subsequently suppressed hypoxia-inducible factor α, which was critical induction CD39/CD73 MDSC. Furthermore, correlated longer overall survival diabetic cancer, accompanied metformin-induced reduction frequency circulating CD39+CD73+ concomitant increase activities CD8+ T cells. Our results highlight direct effect suggest may yield clinical benefit through improvement T-cell immunity dampening CD39/CD73-dependent immunosuppression patients. Significance: The an antidiabetes attributable to reduced immunosuppressive tumor Cancer Res; 78(7); 1779–91. ©2018 AACR.

Language: Английский

Citations

234